In summary, in the malignant progression of LGG ZNF800 can increase the ability of glioma cells to proliferate, migrate, invade, and other malignant biological behaviors, which in turn leads to a poor prognosis of LGG patients. This evidence concerns the gene ZNF800 and central nervous system cancer.